MMED MiniMed Group, Inc. - Common Stock
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Sep 8, 2026
$19.70
· of 52w range
· above low
· to high
$10.6552w low
$24.4352w high
Market Cap (MRQ)
$5.54B
P/E
-15.2
EPS
$-1.30
Revenue
$3.10B
your badges
52W Range
$11–$24
Analyst Rating
BUY
Price Target
$25
P/E
-15.2
ROE
-9.3%
Net Profit Margin
-10.7%
Your badge strip is empty — pin a metric anywhere on this page.
MMED Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$19.70
Market Cap (MRQ)
$5.54B
P/E
-15.2
EPS
$-1.30
Revenue
$3.10B
ROE
-9.3%
52W Range
$11–$24
MMED Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$3.10B2024-04-26 → 2026-04-24
EPS$-1.302024-04-26 → 2026-04-24
Free Cash Flow$-420M2026-04-24 → 2026-04-24
Net margin-10.7%2026-04-24 → 2026-04-24
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | MMED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -15.2 | · | · | · | |
| P/S | 1.8 | · | · | · | |
| P/B (MRQ) | 1.5 | · | · | · | |
| Price / FCF | -13.2 | · | · | · | |
| Price / Cash Flow | -28.1 | · | · | · | |
| Price / Tangible Book (MRQ) | 1.6 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | MMED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 54.2% | · | · | · | |
| Operating Margin | -6.1% | · | · | · | |
| EBITDA Margin | -1.1% | · | · | · | |
| Pretax Margin | -6.1% | · | · | · | |
| Net Profit Margin | -10.7% | · | · | · | |
| ROA | -7.5% | · | · | · | |
| ROE | -9.3% | · | · | · | |
| ROIC | -8.8% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | MMED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.8 | · | · | · | |
| Quick Ratio | 0.7 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | MMED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 14.2% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | MMED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.7 | · | · | · | |
| Inventory Turnover | 4.4 | · | · | · | |
| Receivables Turnover | 8.1 | · | · | · | |
| Revenue / Employee | ≈$387.8K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-235.0%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| March 31, 2027 | Sep 1, 2026 | $0.00 | $0.10 | -100.0% |
| Dec. 31, 2026 | Jun 3, 2026 | $-0.68 | $-0.17 | -291.9% |
| Sept. 30, 2026 | $0.00 | $0.10 | -100.0% | |
| June 30, 2026 | Jun 22, 2026 | $-0.68 | $-0.17 | -291.9% |
| March 31, 2026 | $-0.47 | $0.16 | -391.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue | $3.10B | $2.71B | |
| Cost of Revenue | $1.42B | $1.19B | |
| Gross Profit | $1.68B | $1.53B | |
| SG&A Expense | $1.18B | $1.08B | |
| Operating Income | $-190M | $-146M | |
| Other Non-op | $1M | $-1M | |
| Pretax Income | $-189M | $-147M | |
| Income Tax | $128M | $52M | |
| Net Income | $-333M | $-213M | |
| EPS (Basic) | $-1.30 | $-0.84 | |
| EPS (Diluted) | $-1.30 | $-0.84 | |
| Shares (Basic) | 256,600,000 | 252,800,000 | |
| Shares (Diluted) | 256,600,000 | 252,800,000 | |
| EBITDA | $-34M | · |
Balance Sheet
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Cash & Equivalents | $298M | $11M | |
| Receivables | $200M | $570M | |
| Inventory | $341M | $311M | |
| Other Current Assets | $54M | $48M | |
| Current Assets | $1.35B | $939M | |
| PP&E (Net) | $711M | $706M | |
| PP&E (Gross) | $1.49B | $1.37B | |
| Accum. Depreciation | $781M | $663M | |
| Goodwill | $2.26B | $2.25B | |
| Intangibles | $107M | $132M | |
| Other Non-current Assets | $147M | $150M | |
| Total Assets | $4.63B | $4.20B | |
| Accounts Payable | $163M | $205M | |
| Current Liabilities | $702M | $710M | |
| Capital Leases | $45M | $56M | |
| Other Non-current Liabilities | $317M | $162M | |
| Total Liabilities | $1.02B | $871M | |
| Common Stock | $3M | $0 | |
| Paid-in Capital | $3.74B | $0 | |
| Retained Earnings | $-116M | $0 | |
| AOCI | $-12M | $3M | |
| Stockholders' Equity | $3.61B | $3.33B | |
| Liabilities + Equity | $4.63B | $4.20B | |
| Shares Outstanding | 280,819,988 | 0 |
Cash Flow
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| D&A | $156M | $143M | |
| Stock-based Comp | $46M | $41M | |
| Deferred Tax | $-50M | $-2M | |
| Amort. of Intangibles | $26M | $29M | |
| Other Non-cash | $-16M | · | |
| Operating Cash Flow | $-197M | $140M | |
| CapEx | $223M | $193M | |
| Investing Cash Flow | $-233M | $-193M | |
| Financing Cash Flow | $716M | $10M | |
| Net Change in Cash | $287M | $-43M | |
| Taxes Paid | $2M | $0 | |
| Free Cash Flow | $-420M | · |
Profitability
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Gross Margin | 54.2% | · | |
| Operating Margin | -6.1% | · | |
| Net Margin | -10.7% | · | |
| Pretax Margin | -6.1% | · | |
| EBITDA Margin | -1.1% | · | |
| ROA | -7.5% | · | |
| ROE | -9.3% | · | |
| ROIC | -8.8% | · |
Liquidity & Solvency
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Current Ratio | 1.9 | · | |
| Quick Ratio | 0.7 | · |
Efficiency
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Asset Turnover | 0.7 | · | |
| Inventory Turnover | 4.4 | · | |
| Receivables Turnover | 8.1 | · |
Per Share
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Book Value / Share | $12.86 | · | |
| Revenue / Share | $12.09 | · | |
| Cash Flow / Share | $-0.77 | · | |
| Cash / Share | $1.06 | · | |
| EPS (TTM) | $-1.30 | · |
Growth Rates
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue YoY | 14.2% | 10.0% |
Valuation (TTM)
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue TTM | $3.10B | · | |
| Net Income TTM | $-333M | · | |
| Market Cap | $3.71B | · | |
| P/E | -10.2 | · | |
| P/S | 1.2 | · | |
| P/B | 1.0 | · | |
| P / Tangible Book | 3.0 | · | |
| P / Cash Flow | -18.8 | · | |
| P / FCF | -8.8 | · | |
| Earnings Yield | -9.8% | · |
Income Statement
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $843M | $837M | $790M | $723M | $724M | $687M | |
| Cost of Revenue | $378M | $357M | $428M | $314M | $318M | $292M | |
| Gross Profit | $465M | $480M | $362M | $409M | $405M | $395M | |
| SG&A Expense | $312M | $299M | $309M | $283M | $276M | $268M | |
| Operating Income | $5M | $-93M | $-100M | $-13M | $-148M | $21M | |
| Other Non-op | $0 | $1M | $0 | $0 | $0 | $0 | |
| Pretax Income | $4M | $-92M | $-99M | $-13M | $-148M | $21M | |
| Income Tax | $4M | $93M | $12M | $3M | $21M | $28M | |
| Net Income | $0 | $-185M | $-119M | $-19M | $-172M | $-10M | |
| EPS (Basic) | $0.00 | $-0.71 | $-0.47 | $-0.08 | $-0.68 | $-0.04 | |
| EPS (Diluted) | $0.00 | $-0.71 | $-0.47 | $-0.08 | $-0.68 | $-0.04 | |
| Shares (Basic) | 281,000,000 | · | 252,813,348 | 252,800,000 | · | 252,813,348 | |
| Shares (Diluted) | 281,000,000 | · | 252,813,348 | 252,800,000 | · | 252,813,348 | |
| EBITDA | $46M | · | $-100M | · | · | · |
Balance Sheet
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $207M | $298M | $10M | · | $11M | · | |
| Receivables | $180M | $200M | $653M | · | $570M | · | |
| Inventory | $356M | $341M | $408M | · | $311M | · | |
| Other Current Assets | $72M | $54M | $37M | · | $48M | · | |
| Current Assets | $1.42B | $1.35B | $1.11B | · | $939M | · | |
| PP&E (Net) | $736M | $711M | $701M | · | $706M | · | |
| PP&E (Gross) | · | $1.49B | · | · | $1.37B | · | |
| Accum. Depreciation | · | $781M | · | · | $663M | · | |
| Goodwill | $2.25B | $2.26B | $2.26B | · | $2.25B | · | |
| Intangibles | $100M | $107M | $113M | · | $132M | · | |
| Other Non-current Assets | $152M | $147M | $146M | · | $150M | · | |
| Total Assets | $4.72B | $4.63B | $4.34B | · | $4.20B | · | |
| Accounts Payable | $251M | $163M | $303M | · | $205M | · | |
| Current Liabilities | $782M | $702M | $696M | · | $710M | · | |
| Capital Leases | $50M | $45M | $50M | · | $56M | · | |
| Other Non-current Liabilities | $316M | $317M | $184M | · | $162M | · | |
| Total Liabilities | $1.10B | $1.02B | $881M | · | $871M | · | |
| Common Stock | $3M | $3M | · | · | $0 | · | |
| Paid-in Capital | $3.75B | $3.74B | · | · | $0 | · | |
| Retained Earnings | $-116M | $-116M | · | · | $0 | · | |
| AOCI | $-14M | $-12M | $14M | · | $3M | · | |
| Stockholders' Equity | $3.62B | $3.61B | $3.46B | · | $3.33B | · | |
| Liabilities + Equity | $4.72B | $4.63B | $4.34B | · | $4.20B | · | |
| Shares Outstanding | 281,205,548 | 280,819,988 | · | · | 0 | · |
Cash Flow
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|---|
| D&A | $41M | $39M | · | $39M | $38M | · | |
| Stock-based Comp | $10M | $8M | · | $9M | $9M | · | |
| Amort. of Intangibles | $6M | $6M | $7M | $7M | $7M | $7M | |
| Restructuring | $2M | · | · | · | · | · | |
| Other Non-cash | $-100M | · | · | · | · | · | |
| Operating Cash Flow | $-49M | $-170M | · | $-141M | $83M | · | |
| CapEx | $41M | $56M | · | $53M | $57M | · | |
| Investing Cash Flow | $-41M | $-56M | · | $-63M | $-57M | · | |
| Financing Cash Flow | $0 | $512M | · | $202M | $-25M | · | |
| Net Change in Cash | $-91M | $287M | · | $-2M | $1M | · | |
| Free Cash Flow | $-90M | · | · | · | · | · |
Profitability
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 55.2% | · | 45.8% | · | · | · | |
| Operating Margin | 0.59% | · | -12.7% | · | · | · | |
| Net Margin | 0.00% | · | -15.1% | · | · | · | |
| Pretax Margin | 0.47% | · | -12.5% | · | · | · | |
| EBITDA Margin | 5.5% | · | -12.7% | · | · | · | |
| ROA | 0.00% | · | -5.5% | · | · | · | |
| ROE | 0.00% | · | -6.9% | · | · | · | |
| ROIC | 0.00% | · | -3.2% | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | · | 1.6 | · | · | · | |
| Quick Ratio | 0.5 | · | 1.0 | · | · | · |
Efficiency
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | · | 0.4 | · | · | · | |
| Inventory Turnover | 2.1 | · | 2.1 | · | · | · | |
| Receivables Turnover | 9.4 | · | 2.4 | · | · | · |
Per Share
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $12.87 | · | · | · | · | · | |
| Revenue / Share | $3.00 | · | $3.12 | · | · | · | |
| Cash Flow / Share | $-0.17 | · | · | · | · | · | |
| Cash / Share | $0.74 | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|---|---|
| Market Cap | $5.08B | · | · | · | · | · | |
| P/B | 1.4 | · | · | · | · | · | |
| P / Tangible Book | 4.0 | · | · | · | · | · | |
| P / Cash Flow | -103.6 | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-04-24 | 2025-04-25 | 2024-04-26 |
|---|---|---|---|
| Revenue | $3.10B | $2.71B | $2.47B |
| Gross Margin % | 54.2% | · | · |
| Operating Margin % | -6.1% | · | · |
| Net Income | $-333M | $-213M | $-112M |
| Diluted EPS | $-1.30 | $-0.84 | $-0.44 |
| Metric | 2026-04-24 | 2025-04-25 | 2024-04-26 |
|---|---|---|---|
| Current Ratio | 1.9 | · | · |
| Quick Ratio | 0.7 | · | · |
| Metric | 2026-04-24 | 2025-04-25 | 2024-04-26 |
|---|---|---|---|
| Free Cash Flow | $-420M | · | · |
Company insiders 10 insiders · 6 officers · 5 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Que Dallara | Chief Executive Officer | July 31, 2026 F | 884,749 | 0 | 0 | $0 |
| Chad Spooner | EVP, Chief Financial Officer | July 28, 2026 F | 362,707 | 0 | 0 | $0 |
| Ali Dianaty | EVP Ch. Prod. & Tech Officer | July 31, 2026 F | 315,158 | 0 | 0 | $0 |
| Courtney Nelson Wills | SVP, Gen. Counsel, Corp. Sec. | July 31, 2026 F | 136,384 | 0 | 0 | $0 |
| Gillian Chandrasena | SVP, Chief HR Officer | July 28, 2026 F | 172,745 | 0 | 0 | $0 |
| John Gyurci | VP, Chief Accounting Officer | July 1, 2026 A | 39,941 | 0 | 0 | $0 |
| Kevin E Lofton | Director | March 9, 2026 A | 27,778 | 0 | 0 | $0 |
| Timothy A Wicks | Director | March 9, 2026 A | 13,889 | 0 | 0 | $0 |
| Glenn A Eisenberg | Director | March 9, 2026 A | 13,889 | 0 | 0 | $0 |
| Keith D Grossman | Director | March 9, 2026 A | 13,889 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 7 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 25,024 SH | Aug. 19, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.03% | 3,696 SH | Oct. 1, 2026 | Daily |
| IWM · iShares Trust | 0.02% | 749,142 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 165,581 SH | Aug. 19, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 323,325 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,442 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 267,021 SH | Sept. 11, 2026 | Daily |
MMED Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 18 analysts
BUY
Median target
$26.00
+32.0%
6 33.3%
Strong Buy
10 55.6%
Buy
2 11.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
12 analysts · 2026-09-30Mean target $24.92 +26.5%
Now
Current price $19.70
Low$15.00
Mean$24.92
High$29.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MDLN | · | -4200.0 | 11.5% | 4.1% | 21.6% | 26.4% |
| SOLV | $13.75B | 8.9 | 0.86% | 18.7% | 35.8% | 53.5% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Sep 8, 2026